Detalles de la búsqueda
1.
An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom.
Clin Drug Investig
; 2024 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38796677
2.
Treatment Patterns and Health Resource Utilization in Patients With HR+/ HER2- Locally Advanced or Metastatic Breast Cancer in a Real-World Setting in Taiwan.
Value Health Reg Issues
; 36: 98-104, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37086714
3.
A cost comparison of benralizumab, mepolizumab, and dupilumab in patients with severe asthma: A US third-party payer perspective.
J Manag Care Spec Pharm
; 29(11): 1193-1204, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37796731
4.
Treatment Patterns, Clinical Outcomes and Health Care Resource Utilisation in Patients with EGFR-mutated Metastatic Non-Small Cell Lung Cancer: A Real-World Study in South Korea.
Drugs Real World Outcomes
; 10(1): 131-143, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36456850
5.
Real-World Treatment Patterns and Health-Resource Utilization in Patients with Hepatocellular Carcinoma (HCC) Following Failure of Sorafenib: A Retrospective Chart Review of 127 Patients in South Korea.
Drugs Real World Outcomes
; 9(2): 263-274, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34905182
6.
Treatment Patterns and Health Resource Utilization in Patients With Hepatocellular Carcinoma After Failure of Sorafenib in Real-World Setting in Taiwan.
Value Health Reg Issues
; 30: 76-82, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35278836
7.
Real world evidence study on treatment patterns and health resource utilization in patients with HR+/HER2- locally advanced or metastatic breast cancer in Korea.
J Drug Assess
; 11(1): 12-19, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35967262
8.
Socio-demographic indicators of self-reported health based on EQ-5D-3L: A cross-country analysis of population surveys from 18 countries.
Front Public Health
; 10: 959252, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36684894
9.
Assessment of rituximab-abbs, a biosimilar, and rituximab outcomes in patients with CLL or NHL: A real-world UK study.
Leuk Res
; 111: 106671, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34530254
10.
Cost effectiveness of benralizumab for severe, uncontrolled oral corticosteroid-dependent asthma in Sweden.
J Med Econ
; 23(8): 877-884, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32324093
11.
Valuation of transfusion-free living in MDS: results of health utility interviews with patients.
Health Qual Life Outcomes
; 7: 81, 2009 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-19737399
12.
RWE Framework: An Interactive Visual Tool to Support a Real-World Evidence Study Design.
Drugs Real World Outcomes
; 6(4): 193-203, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31741199
13.
Evaluation of pain relief treatment and timelines in emergency care in six European countries and Australia.
Open Access Emerg Med
; 11: 229-240, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31572027
14.
THE AUTHORS RESPOND.
J Manag Care Spec Pharm
; 30(4): 398-399, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38555629
15.
The inequity of informal payments for health care: the case of Hungary.
Health Policy
; 75(3): 262-71, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15913832
16.
Psychometric and utility-based measures of health status of asthmatic patients with different disease control level.
Pharmacoeconomics
; 22(8): 537-47, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15217309
17.
Health care reform in six Central European countries. A focus on health economic requirements in the drug pricing and reimbursement processes.
Eur J Health Econ
; 4(4): 286-91, 2003 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-15609197
18.
[Health-related quality of life of the Hungarian population]. / A magyar lakosság egészségi állapothoz kapcsolódó életminósége.
Orv Hetil
; 144(34): 1667-74, 2003 Aug 24.
Artículo
en Húngaro
| MEDLINE | ID: mdl-14528840
19.
Medical resource utilization and associated costs in patients with ulcerative colitis in the UK: a chart review analysis.
Eur J Gastroenterol Hepatol
; 26(2): 213-21, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24145865
20.
Cost-effectiveness and budgetary impact of lipegfilgrastim for the reduction of chemotherapy-induced neutropenia in Brazil / Custo-benefício e impacto orçamentário do lipegfilgrastim para a redução de neutropenia induzida por quimioterapia no Brasil
J. bras. econ. saúde (Impr.)
; 10(2): 107-117, Agosto/2018.
Artículo
en Inglés
| LILACS, ECOS | ID: biblio-914921